AF
Aquamarine Financial (Cayman) Ltd disclosed a 6.4% stake in ORMP
Aquamarine Financial (Cayman) Ltd reported owning 6.4% of Oramed Pharmaceuticals Inc. (ORMP) (2,653,567 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G